Spacers Increase the Accessibility of Peptide Ligands Linked to the Carboxyl Terminus of Adenovirus Minor Capsid Protein IX

ABSTRACT The efficiency and specificity of gene transfer with human adenovirus (hAd)-derived gene transfer vectors would be improved if the native viral tropism could be modified. Here, we demonstrate that the minor capsid protein IX (pIX), which is present in 240 copies in the Ad capsid, can be exploited as an anchor for heterologous polypeptides. Protein IX-deleted hAd5 vectors were propagated in hAd5 helper cells expressing pIX variants, with heterologous carboxyl-terminal extensions of up to 113 amino acids in length. The extensions evaluated consist of alpha-helical spacers up to 75 Å in length and to which peptide ligands were fused. The pIX variants were efficiently incorporated into the capsids of Ad particles. On intact particles, the MYC-tagged-pIX molecules were readily accessible to anti-MYC antibodies, as demonstrated by electron microscopic analyses of immunogold-labeled virus particles. The labeling efficiency improved with increasing spacer length, suggesting that the spacers lift and expose the ligand at the capsid surface. Furthermore, we found that the addition of an integrin-binding RGD motif to the pIX markedly stimulated the transduction of coxsackievirus group B and hAd receptor-deficient endothelioma cells, demonstrating the utility of pIX modification in gene transfer. Our data demonstrate that the minor capsid protein IX can be used as an anchor for the addition of polypeptide ligands to Ad particles.

[1]  Erkki Ruoslahti,et al.  αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.

[2]  D. Curiel,et al.  Modulation of Adenovirus Vector Tropism via Incorporation of Polypeptide Ligands into the Fiber Protein , 2002, Journal of Virology.

[3]  R. M. Burnett,et al.  Molecular composition of the adenovirus type 2 virion , 1985, Journal of virology.

[4]  D. Brough,et al.  The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F , 1998, Journal of Virology.

[5]  J. T. Douglas Targeted adenoviral vectors , 2002 .

[6]  J. Bergelson,et al.  The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Bewley,et al.  Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. , 1999, Science.

[8]  A. Houweling,et al.  Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. , 1996, Human gene therapy.

[9]  Senén Vilaró,et al.  RGD Peptides and Monoclonal Antibodies, Antagonists of αv-Integrin, Enter the Cells by Independent Endocytic Pathways , 2001, Laboratory Investigation.

[10]  R. M. Burnett,et al.  Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography. , 1989, The EMBO journal.

[11]  M. Magnusson,et al.  Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability , 2002, The journal of gene medicine.

[12]  H. Granzow,et al.  The Subgenus-Specific C-Terminal Region of Protein IX Is Located on the Surface of the Adenovirus Capsid , 1999, Journal of Virology.

[13]  E Ruoslahti,et al.  Solution structures and integrin binding activities of an RGD peptide with two isomers. , 2001, Biochemistry.

[14]  D. Curiel,et al.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism , 1996, Journal of virology.

[15]  D. Curiel,et al.  Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 Fibritin , 2001, Journal of Virology.

[16]  U. Pettersson,et al.  Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. , 1973, Virology.

[17]  G. Nemerow Cell receptors involved in adenovirus entry. , 2000, Virology.

[18]  A. van der Eb,et al.  New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. , 1998, Human gene therapy.

[19]  Roger M. Burnett,et al.  Image reconstruction reveals the complex molecular organization of adenovirus , 1991, Cell.

[20]  D. Curiel,et al.  Engineering of Adenovirus Vectors Containing Heterologous Peptide Sequences in the C Terminus of Capsid Protein IX , 2002, Journal of Virology.

[21]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[22]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Brough,et al.  Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins , 1997, Journal of virology.

[24]  H. Hamada,et al.  Reduction of Natural Adenovirus Tropism to the Liver by both Ablation of Fiber-Coxsackievirus and Adenovirus Receptor Interaction and Use of Replaceable Short Fiber , 2003, Journal of Virology.

[25]  G. Molema,et al.  Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[26]  M. Dabauvalle,et al.  Cellular uptake and nuclear delivery of recombinant adenovirus penton base. , 1999, Virology.

[27]  J. Bos,et al.  Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformation. , 1983, Virology.

[28]  S. J. Flint,et al.  Interactions among the three adenovirus core proteins , 1985, Journal of virology.

[29]  P. Nygren,et al.  Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. , 2002, Human gene therapy.

[30]  P. Stewart,et al.  Difference imaging of adenovirus: bridging the resolution gap between X‐ray crystallography and electron microscopy. , 1993, The EMBO journal.

[31]  F. Graham,et al.  Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. , 1995, Human gene therapy.

[32]  W. Russell,et al.  Update on adenovirus and its vectors. , 2000, The Journal of general virology.

[33]  G. Nemerow,et al.  Adenovirus Vector Pseudotyping in Fiber-Expressing Cell Lines: Improved Transduction of Epstein-Barr Virus-Transformed B Cells , 2000, Journal of Virology.

[34]  H. Mizuguchi,et al.  Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. , 2002, Gene.

[35]  T. Shenk,et al.  Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX , 1981, Journal of virology.

[36]  R. Crystal,et al.  Fiber Swap between Adenovirus Subgroups B and C Alters Intracellular Trafficking of Adenovirus Gene Transfer Vectors , 1999, Journal of Virology.

[37]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[38]  H. Pereira,et al.  Antigens and structure of the adenovirus , 2003, Journal of molecular biology.

[39]  K. Leppard,et al.  Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5 , 1995, Journal of virology.

[40]  J. Gall,et al.  Subgroup B and F Fiber Chimeras Eliminate Normal Adenovirus Type 5 Vector Transduction In Vitro and In Vivo , 2003, Journal of Virology.

[41]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[42]  P. Boulanger,et al.  Characterization of adenovirus protein IX. , 1979, The Journal of general virology.

[43]  N R Kallenbach,et al.  Structural analysis of the N‐ and C‐termini in a peptide with consensus sequence , 1995, Protein science : a publication of the Protein Society.

[44]  C. Kedinger,et al.  Functional Analysis of Adenovirus Protein IX Identifies Domains Involved in Capsid Stability, Transcriptional Activity, and Nuclear Reorganization , 2001, Journal of Virology.

[45]  A. Kidd,et al.  Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor , 2000, Journal of Virology.

[46]  S. Khoo,et al.  Adenoviruses from Human Immunodeficiency Virus-Infected Individuals, Including Two Strains That Represent New Candidate Serotypes Ad50 and Ad51 of Species B1 and D, Respectively , 1999, Journal of Clinical Microbiology.

[47]  U. Pettersson,et al.  Structural proteins of adenoviruses , 1971 .

[48]  T. Wickham,et al.  Targeting adenovirus , 2000, Gene Therapy.

[49]  Manfred Schwab,et al.  Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. , 2002, Cancer research.

[50]  R. Auerbach,et al.  A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[51]  F. Graham,et al.  Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. , 1987, The EMBO journal.

[52]  P. Boulanger,et al.  Human adenovirus type 2 protein IIIa. II. Maturation and encapsidation. , 1980, Virology.

[53]  R. Miceli,et al.  Two-stage selection of sequences from a random phage display library delineates both core residues and permitted structural range within an epitope. , 1994, Journal of immunological methods.